Enveric Biosciences to Participate in Wonderland: Miami Conference

Rhea-AI Summary

Enveric Biosciences (NASDAQ: ENVB) has announced that CEO Dr. Joseph Tucker will speak at the Microdose Presents Wonderland conference in Miami on November 8-9, 2021. Dr. Tucker is scheduled to participate in the Next-Generation Psychedelics panel on November 8 at 3:10 p.m. ET. Enveric is focused on developing innovative treatments for mental health and oncology using psychedelic-derived molecules and synthetic cannabinoids.

For details on attendance and meetings, interested parties can contact Microdose representatives or email KCSA Strategic Communications.

NAPLES, Fla., Oct. 26, 2021 /PRNewswire/ -- Enveric Biosciences (NASDAQ: ENVB) ("Enveric" or the "Company"), a patient-centric biotechnology company developing next-generation mental health and oncology treatments by leveraging psychedelic-derived molecules for the mind and synthetic cannabinoids for the body, today announced that Dr. Joseph Tucker, Chief Executive Officer of Enveric Biosciences, will participate in the upcoming Wonderland: Miami conference:

• Microdose Presents Wonderland: Miami to be held in-person in Miami, Florida from November 8-9, 2021. Dr. Tucker will be speaking on the Next-Generation Psychedelics panel live on Monday, November 8^th at 3:10 p.m. ET. Register to attend here.

For more information about the conferences, or to schedule a one-on-one meeting with Enveric's management team, please contact your Microdose representatives directly, or send an email to KCSA Strategic Communications at envericbio@kcsa.com.

About Enveric Biosciences 
Enveric Biosciences (NASDAQ: ENVB) is an innovative biotechnology company developing a next-generation mental health and oncology treatment clinical discovery platform, leveraging psychedelic-derived molecules for the mind and synthetic cannabinoids for the body. Enveric's robust pipeline supports drug development from the clinic to commercialization for millions of patients in need around the world suffering from conditions that include cancer-related distress, PTSD and more. For more information, please visit www.enveric.com.

Investor Contacts
Valter Pinto / Allison Soss
KCSA Strategic Communications
212.896.1254 / 212.896.1267
valter@kcsa.com / asoss@kcsa.com 

Media Contacts
Raquel Cona / Joe McIntyre
KCSA Strategic Communications
212.896.1204 / 856.381.8996
rcona@kcsa.com  / jmcintyre@kcsa.com

View original content:https://www.prnewswire.com/news-releases/enveric-biosciences-to-participate-in-wonderland-miami-conference-301408112.html

SOURCE Enveric Biosciences

FAQ

What is the purpose of Enveric Biosciences' participation in the Wonderland conference?

Enveric Biosciences aims to showcase its innovative approaches to mental health and oncology treatments at the Wonderland conference.

When will Dr. Joseph Tucker speak at the Wonderland conference?

Dr. Joseph Tucker will speak on November 8, 2021, at 3:10 p.m. ET.

Where is the Wonderland conference being held?

The Wonderland conference is being held in Miami, Florida.

What are the dates of the Wonderland conference?

The Wonderland conference takes place from November 8-9, 2021.

How can I register for the Wonderland conference?

Registration details for the Wonderland conference can be found on the Microdose event website.